Heinrich Haas

Heinrich Haas

Company: BioNTech AG

Job title: Vice President Formulation and Drug Development

Email: heinrich.haas@biontech.de


Overcoming RNA-Based Vaccine Challenges for Effective Cancer Vaccine Therapy 5:15 pm

• Clarifying the success of the RNA-based platform due to the COVID-19 vaccine is easily translatable to cancer vaccine • Improving vaccine activity by combining with RNA encoded cytokinesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.